Jade Biosciences (JBIO) Profit After Tax (2020 - 2026)
Jade Biosciences posted quarterly Profit After Tax of -$40.4 million for Q1 2026, down 5.76% year-on-year from -$42.8 million in Q1 2025, and down 26.42% on a QoQ basis from -$31.9 million in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Profit After Tax data on file, last reported at -$40.4 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 5.76% year-over-year to -$40.4 million; the trailing twelve-month figure through Mar 2026 stood at -$129.6 million (down 27.05% YoY), and the FY2025 full-year result was -$127.4 million, down 82.99% from the prior year.
- Profit After Tax for Q1 2026 stood at -$40.4 million, down from -$31.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$590000.0 in Q2 2024 and bottomed at -$47.0 million in Q4 2024.
- The 5-year median for Profit After Tax is -$19.6 million (2023), against an average of -$22.5 million.
- The widest annual swing landed in 2024, when Profit After Tax soared 96.9%; it then plunged 5346.44% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$15.0 million in 2022, then tumbled by 35.89% to -$20.4 million in 2023, then tumbled by 130.14% to -$47.0 million in 2024, then surged by 32.03% to -$31.9 million in 2025, then fell by 26.42% to -$40.4 million in 2026.
- The last three Profit After Tax figures came in at -$40.4 million (Q1 2026), -$31.9 million (Q4 2025), and -$25.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | -40.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.37 Mn |
| Dec 31, 2025 | -31.93 Mn |
| Sep 30, 2025 | -25.18 Mn |
| Jun 30, 2025 | -32.13 Mn |
| Mar 31, 2025 | -38.17 Mn |
| Dec 31, 2024 | -46.98 Mn |
| Sep 30, 2024 | -16.28 Mn |
| Jun 30, 2024 | -590,000.00 |
| Mar 31, 2024 | -23.19 Mn |
| Dec 31, 2023 | -20.41 Mn |
| Sep 30, 2023 | -19.56 Mn |
| Jun 30, 2023 | -19.03 Mn |
| Mar 31, 2023 | -16.52 Mn |
| Dec 31, 2022 | -15.02 Mn |
| Sep 30, 2022 | -13.59 Mn |
| Jun 30, 2022 | -11.99 Mn |
| Mar 31, 2022 | -10.91 Mn |
| Dec 31, 2021 | -8.22 Mn |
| Sep 30, 2021 | -6.18 Mn |
| Jun 30, 2021 | -5.78 Mn |
| Mar 31, 2021 | -2.78 Mn |
| Dec 31, 2020 | -3.67 Mn |
| Sep 30, 2020 | -2.31 Mn |
| Jun 30, 2020 | -2.20 Mn |